161 results on '"Zhou, Hua-Fu"'
Search Results
2. CDK6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma
3. Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms
4. CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
5. A novel prognostic signature of coagulation-related genes leveraged by machine learning algorithms for lung squamous cell carcinoma
6. Correlation between hemoglobin and the risk of common malignant tumors: a 1999–2020 retrospective analysis and causal association analysis
7. Risk factors for one-year mortality following discharge in patients with acute aortic dissection: development and validation of a predictive model in a cross-sectional study
8. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer
9. Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
10. The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
11. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers
12. MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma
13. Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism
14. The clinical significance and mechanism of microRNA-22-3p targeting TP53 in lung adenocarcinoma
15. MMP12 serves as an immune cell–related marker of disease status and prognosis in lung squamous cell carcinoma
16. Prognostic Signature and Discrimination Signature of Lung Adenocarcinoma based on Pyroptosis-Related Genes
17. Additional file 3 of Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms
18. Additional file 3 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
19. Additional file 13 of Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms
20. Additional file 4 of Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms
21. Additional file 5 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
22. Additional file 1 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
23. Additional file 2 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
24. Additional file 4 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
25. Additional file 5 of Gene S-phase kinase associated protein 2 is a novel prognostic marker in human neoplasms
26. Additional file 6 of CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
27. A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis
28. The Clinical Significance of Integrin Subunit Alpha V in Cancers: From Small Cell Lung Carcinoma to Pan-cancer
29. An updated meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer
30. Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer
31. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma
32. Additional file 2 of Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
33. Additional file 5 of SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer
34. Additional file 1 of The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
35. Additional file 4 of The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
36. Additional file 9 of Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
37. Additional file 6 of The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer
38. The Clinical Significance of Forkhead Box M1 in Esophageal Squamous Cell Carcinoma Tissues: A Study Based on In-house Immunohistochemistry, RNA-sequencing, and Data Mining
39. Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma
40. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma
41. Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
42. The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung
43. A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects
44. An updated meta-analysis for association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer
45. Association of glutathione S-transferase P1 gene polymorphism with the histological types of lung cancer: a meta-analysis
46. Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer
47. The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma
48. Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods
49. Integrated expression analysis revealed RUNX2 upregulation in lung squamous cell carcinoma tissues
50. Downregulation of miRNA‐126‐3p is associated with progression of and poor prognosis for lung squamous cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.